CXCR4 and leukemia: Here, [68Ga]Pentixafor PET enabled visualization of CXCR4-positive leukemic burden, and CXCR4-directed ERT with [177Lu]Pentixather resulted in the efficient reduction of leukemia in leukemia-harboring tissues (spleen, bone marrow).